{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:59:02Z","timestamp":1788919142833,"version":"build-2803163510"},"reference-count":148,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9,15]]},"DOI":"10.1097\/tp.0b013e3182547537","type":"journal-article","created":{"date-parts":[[2012,8,14]],"date-time":"2012-08-14T07:20:48Z","timestamp":1344928848000},"page":"425-441","source":"Crossref","is-referenced-by-count":61,"title":["Review of Randomized Clinical Trials of Donor Management and Organ Preservation in Deceased Donors"],"prefix":"10.1097","volume":"94","author":[{"given":"George S.","family":"Dikdan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Mora-Esteves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baburao","family":"Koneru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210129","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00134-005-2662-9","article-title":". Efficiency of triiodothyronine treatment on organ donor hemodynamic management and adenine nucleotide concentration.","volume":"31","author":"Perez-Blanco","year":"2005","journal-title":"Intensive Care Med"},{"key":"R2-1-20210129","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/00003246-199007000-00004","article-title":". Hormonal changes in brain dead patients.","volume":"18","author":"Powner","year":"1990","journal-title":"Crit Care Med"},{"key":"R3-1-20210129","first-page":"851","article-title":"Bickel U, et al..","volume":"54","author":"Gramm","year":"1992","journal-title":"Acute endocrine failure after brain death Transplantation"},{"key":"R4-1-20210129","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1097\/01.tp.0000237195.12342.f1","article-title":". Hormonal therapy of the brain-dead organ donor: experimental and clinical studies.","volume":"82","author":"Novitzky","year":"2006","journal-title":"Transplantation"},{"key":"R5-1-20210129","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/eurheartj\/ehp086","article-title":". The haemodynamic effects of adjunctive hormone therapy in potential heart donors: a prospective randomized double-blind factorially designed controlled trial.","volume":"30","author":"Venkateswaran","year":"2009","journal-title":"Eur Heart J"},{"key":"R6-1-20210129","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/00003246-199608000-00014","article-title":". Hormonal and hemodynamic changes in a validated animal model of brain death.","volume":"24","author":"Chen","year":"1996","journal-title":"Crit Care Med"},{"key":"R7-1-20210129","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00007890-198801000-00008","article-title":". Change from aerobic to anaerobic metabolism after brain death, and reversal following triiodothyronine therapy.","volume":"45","author":"Novitzky","year":"1988","journal-title":"Transplantation"},{"key":"R8-1-20210129","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00007890-198411000-00003","article-title":". Vasopressin supplementation in a porcine model of brain-dead potential organ donors.","volume":"38","author":"Blaine","year":"1984","journal-title":"Transplantation"},{"key":"R9-1-20210129","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.healun.2005.07.010","article-title":". Glucocorticoid administration reduces cardiac dysfunction after brain death in pigs.","volume":"24","author":"Lyons","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R10-1-20210129","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0140-6736(98)05456-7","article-title":". Administration of desmopressin in brain-dead donors and renal function in kidney recipients.","volume":"352","author":"Guesde","year":"1998","journal-title":"Lancet"},{"key":"R11-1-20210129","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00007890-198307000-00024","article-title":". Effect of dopamine and pitressin on kidneys procured and harvested for transplantation.","volume":"36","author":"Schneider","year":"1983","journal-title":"Transplantation"},{"key":"R12-1-20210129","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/0002-9343(87)90228-2","article-title":"Vasopressin as vasopressor.","volume":"82","author":"Goldsmith","year":"1987","journal-title":"Am J Med"},{"key":"R13-1-20210129","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00007890-199501150-00011","article-title":". Use of low dose arginine vasopressin to support brain-dead organ donors.","volume":"59","author":"Pennefather","year":"1995","journal-title":"Transplantation"},{"key":"R14-1-20210129","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1432-2277.1990.tb01879.x","article-title":". Long-term renal preservation after brain death maintained with vasopressin and epinephrine.","volume":"3","author":"Kinoshita","year":"1990","journal-title":"Transpl Int"},{"key":"R15-1-20210129","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/01.TP.0000045683.85282.93","article-title":". Aggressive pharmacologic donor management results in more transplanted organs.","volume":"75","author":"Rosendale","year":"2003","journal-title":"Transplantation"},{"key":"R16-1-20210129","first-page":"1535","article-title":"Improved cardiac transplant survival with thyroxine treatment of hemodynamically unstable donors: 95.2 graft survival at 6 and 30 months.","volume":"25","author":"Orlowski","year":"1993","journal-title":"Transplant Proc"},{"key":"R17-1-20210129","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/thy.1997.7.139","article-title":"Triiodothyronine: spectrum of use in heart transplantation.","volume":"7","author":"Jeevanandam","year":"1997","journal-title":"Thyroid"},{"key":"R18-1-20210129","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1097\/01.CCM.0000146133.52982.17","article-title":". The effect of a thyroid hormone infusion on vasopressor support in critically ill children with cessation of neurologic function.","volume":"32","author":"Zuppa","year":"2004","journal-title":"Crit Care Med"},{"key":"R19-1-20210129","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.healun.2009.12.001","article-title":". Increased recovery of thoracic organs after hormonal resuscitation therapy.","volume":"29","author":"Nath","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"R20-1-20210129","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0750-7658(05)80806-8","article-title":". Value of hormonal treatment with triiodothyronine and cortisone in brain dead patients in French.","volume":"10","author":"Mariot","year":"1991","journal-title":"Ann Franc Anesth Reanim"},{"key":"R21-1-20210129","first-page":"2495","article-title":". Effects of substitutive triiodothyronine therapy on intracellular nucleotide levels in donor organs.","volume":"23","author":"Garcia-Fages","year":"1991","journal-title":"Transplant Proc"},{"key":"R22-1-20210129","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/00007890-199210000-00034","article-title":"Triiodothyronine treatment in brain-dead multiorgan donorsa controlled study.","volume":"54","author":"Randell","year":"1992","journal-title":"Transplantation"},{"key":"R23-1-20210129","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1213\/00000539-199607000-00008","article-title":". The effects of triiodothyronine on hemodynamic status and cardiac function in potential heart donors.","volume":"83","author":"Goarin","year":"1996","journal-title":"Anesth Analg"},{"key":"R24-1-20210129","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.athoracsur.2007.07.092","article-title":". Early donor management increases the retrieval rate of lungs for transplantation.","volume":"85","author":"Venkateswaran","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"R25-1-20210129","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1399-6576.1990.tb03151.x","article-title":"Peroperative fluid management of the brain-dead multiorgan donor.","volume":"34","author":"Randell","year":"1990","journal-title":"Acta Anaesthesiol Scand"},{"key":"R26-1-20210129","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/S0140-6736(96)07588-5","article-title":". Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients.","volume":"348","author":"Cittanova","year":"1996","journal-title":"Lancet"},{"key":"R27-1-20210129","first-page":"1465","article-title":". Modification of donor pretreatment prolongs canine renal allograft survival.","volume":"11","author":"Dienst","year":"1979","journal-title":"Transplant Proc"},{"key":"R28-1-20210129","first-page":"183","article-title":"Donor pretreatment in cadaver renal transplantation.","volume":"145","author":"Zincke","year":"1977","journal-title":"Surg Gynecol Obstet"},{"key":"R29-1-20210129","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0090-4295(77)90154-6","article-title":"Effect of high doses of intravenous methylprednisolone and cyclophosphamide on renal homografts.","volume":"10","author":"Zincke","year":"1977","journal-title":"Urology"},{"key":"R31-1-20210129","first-page":"1597","article-title":"Statewide donor pretreatment study.","volume":"9","author":"Dienst","year":"1977","journal-title":"Transplant Proc"},{"key":"R32-1-20210129","first-page":"729","article-title":". Pretreatment of cadaver donors with methylprednisolone in human renal allografts.","volume":"145","author":"Chatterjee","year":"1977","journal-title":"Surg Gynecol Obstet"},{"key":"R33-1-20210129","first-page":"709","article-title":". A prospective randomized double-blind controlled study of cadaver donor pretreatment with cyclophosphamide in human renal transplantation.","volume":"13","author":"Chatterjee","year":"1981","journal-title":"Transplant Proc"},{"key":"R34-1-20210129","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000181714","article-title":". Steroid-cyclophosphamide pretreatment of kidney allograft donors. A control study.","volume":"24","author":"Soulillou","year":"1979","journal-title":"Nephron"},{"key":"R35-1-20210129","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00000658-200112000-00004","article-title":". Improvements in early behavior of rat kidney allografts after treatment of the brain-dead donor.","volume":"234","author":"Pratschke","year":"2001","journal-title":"Ann Surg"},{"key":"R36-1-20210129","first-page":"423","article-title":"Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death.","volume":"17","author":"Follette","year":"1998","journal-title":"J Heart Lung Transplant"},{"key":"R37-1-20210129","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1097\/01.TP.0000062839.58826.6D","article-title":". Hormonal resuscitation yields more transplanted hearts, with improved early function.","volume":"75","author":"Rosendale","year":"2003","journal-title":"Transplantation"},{"key":"R38-1-20210129","doi-asserted-by":"crossref","first-page":"222","DOI":"10.7326\/0003-4819-153-4-201008170-00003","article-title":". Steroid pretreatment of organ donors to prevent postischemic renal allograft failure: a randomized, controlled trial.","volume":"153","author":"Kainz","year":"2010","journal-title":"Ann Intern Med"},{"key":"R39-1-20210129","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/SLA.0b013e318190e70c","article-title":". Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial.","volume":"248","author":"Kotsch","year":"2008","journal-title":"Ann Surg"},{"key":"R40-1-20210129","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1034\/j.1600-6143.2002.20810.x","article-title":". Increased transplanted organs from the use of a standardized donor management protocol.","volume":"2","author":"Rosendale","year":"2002","journal-title":"Am J Transplant"},{"key":"R41-1-20210129","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1600-6143.2008.02205.x","article-title":"Deceased organ donor characteristics and clinical interventions associated with organ yield.","volume":"8","author":"Selck","year":"2008","journal-title":"Am J Transplant"},{"key":"R42-1-20210129","first-page":"289","article-title":". Verapamil prevents post-transplant oliguric renal failure.","volume":"24","author":"Duggan","year":"1985","journal-title":"Clin Nephrol"},{"key":"R43-1-20210129","first-page":"905","article-title":"Kornberger R, et al..","volume":"20","author":"Koller","year":"1988","journal-title":"Does systemic pretreatment with verapamil prevent acute tubular necrosis after renal transplantation Transplant Proc"},{"key":"R44-1-20210129","first-page":"1221","article-title":"Prevention of delayed graft function by diltiazem and iloprost.","volume":"21","author":"Neumayer","year":"1989","journal-title":"Transplant Proc"},{"key":"R45-1-20210129","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/jama.2009.1310","article-title":". Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial.","volume":"302","author":"Schnuelle","year":"2009","journal-title":"JAMA"},{"key":"R46-1-20210129","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/00007890-199904270-00007","article-title":". Preconditioning of donor livers with prostaglandin I2 before retrieval decreases hepatocellular ischemia-reperfusion injury.","volume":"67","author":"Klein","year":"1999","journal-title":"Transplantation"},{"key":"R47-1-20210129","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1111\/tri.1992.5.s1.110","article-title":". Protective effect of vasodilators in donors requiring pressor support.","volume":"5","author":"Pontin","year":"1992","journal-title":"Transpl Int"},{"key":"R48-1-20210129","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/lt.21630","article-title":". Ischemic preconditioning of the liver: a few perspectives from the bench to bedside translation.","volume":"14","author":"Desai","year":"2008","journal-title":"Liver Transpl"},{"key":"R49-1-20210129","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/01.sla.0000167848.96692.ad","article-title":". Effects of 10 minutes of ischemic preconditioning of the cadaveric liver on the grafts preservation and function: the ying and the yang.","volume":"242","author":"Azoulay","year":"2005","journal-title":"Ann Surg"},{"key":"R50-1-20210129","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/lt.20315","article-title":". Ischemic preconditioning in deceased donor liver transplantation: a prospective randomized clinical trial of safety and efficacy.","volume":"11","author":"Koneru","year":"2005","journal-title":"Liver Transpl"},{"key":"R51-1-20210129","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/lt.20640","article-title":". Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study.","volume":"12","author":"Cescon","year":"2006","journal-title":"Liver Transpl"},{"key":"R52-1-20210129","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1111\/j.1600-6143.2007.01914.x","article-title":". Ischemic pre-conditioning in deceased donor liver transplantation: a prospective randomized clinical trial.","volume":"7","author":"Amador","year":"2007","journal-title":"Am J Transplant"},{"key":"R53-1-20210129","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1111\/j.1600-6143.2007.02009.x","article-title":". The ischemic preconditioning paradox in deceased donor liver transplantationevidence from a prospective randomized single blind clinical trial.","volume":"7","author":"Koneru","year":"2007","journal-title":"Am J Transplant"},{"key":"R54-1-20210129","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1111\/j.1600-6143.2009.02680.x","article-title":". Ischemic preconditioning (IP) of the liver as a safe and protective technique against ischemiareperfusion injury (IRI).","volume":"9","author":"Franchello","year":"2009","journal-title":"Am J Transplant"},{"issue":"1","key":"R55-1-20210129","first-page":"CD006315","article-title":"Ischaemic preconditioning for liver transplantation.","author":"Gurusamy","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"R56-1-20210129","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/SLA.0b013e31818f3dda","article-title":". A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic.","volume":"248","author":"Beck-Schimmer","year":"2008","journal-title":"Ann Surg"},{"key":"R57-1-20210129","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/j.jvca.2006.05.012","article-title":". Myocardial damage prevented by volatile anesthetics: a multicenter randomized controlled study.","volume":"20","author":"Guarracino","year":"2006","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R58-1-20210129","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1213\/ane.0b013e3181a27e4b","article-title":". Helium breathing provides modest antiinflammatory, but no endothelial protection against ischemia-reperfusion injury in humans in vivo.","volume":"109","author":"Lucchinetti","year":"2009","journal-title":"Anesth Analg"},{"key":"R59-1-20210129","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1111\/j.1600-6143.2010.03289.x","article-title":". Intraoperative administration of inhaled carbon monoxide reduces delayed graft function in kidney allografts in swine.","volume":"10","author":"Hanto","year":"2010","journal-title":"Am J Transplant"},{"key":"R60-1-20210129","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1002\/lt.21918","article-title":". Liver graft exposure to carbon monoxide during cold storage protects sinusoidal endothelial cells and ameliorates reperfusion injury in rats.","volume":"15","author":"Ikeda","year":"2009","journal-title":"Liver Transpl"},{"key":"R61-1-20210129","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/0003-4975(96)00108-7","article-title":". Extended lung preservation with the use of hibernation trigger factors.","volume":"61","author":"Oeltgen","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"R62-1-20210129","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0003-4975(01)03084-3","article-title":". Opioid preconditioning: myocardial function and energy metabolism.","volume":"72","author":"Sigg","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"R63-1-20210129","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/01.TP.0000056633.50445.AC","article-title":". Preconditioning of donors with interleukin-10 reduces hepatic ischemia-reperfusion injury after liver transplantation in pigs.","volume":"75","author":"Donckier","year":"2003","journal-title":"Transplantation"},{"key":"R64-1-20210129","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jtcvs.2005.09.049","article-title":". Glycine intravenous donor preconditioning is superior to glycine supplementation to low-potassium dextran flush preservation and improves graft function in a large animal lung transplantation model after 24 hours of cold ischemia.","volume":"131","author":"Gohrbandt","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R65-1-20210129","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ejcts.2009.10.029","article-title":". Pre-ischaemic conditioning of the pulmonary endothelium by immunotargeting of catalase via angiotensin-converting-enzyme antibodies.","volume":"37","author":"Nowak","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"R66-1-20210129","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/CCM.0b013e3181feeb04","article-title":". Informed consent in research to improve the number and quality of deceased donor organs.","volume":"39","author":"Rey","year":"2011","journal-title":"Crit Care Med"},{"key":"R67-1-20210129","first-page":"1155","article-title":"Donor intervention and organ preservation: where is the science and what are the obstacles Am J T","volume":"10","author":"Feng","year":"2010","journal-title":"ransplant"},{"key":"R68-1-20210129","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/CCM.0b013e318206b0eb","article-title":"Resolving issues of consent and oversight: one step closer to terra firma in deceased organ donor research.","volume":"39","author":"Mora-Esteves","year":"2011","journal-title":"Crit Care Med"},{"key":"R69-1-20210129","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1097\/CCM.0b013e318174d89f","article-title":". Increased plasma interleukin-6 in donors is associated with lower recipient hospital-free survival after cadaveric organ transplantation.","volume":"36","author":"Murugan","year":"2008","journal-title":"Crit Care Med"},{"key":"R70-1-20210129","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/ki.2010.351","article-title":". Urine neutrophil gelatinase-associated lipocalin is a marker of graft recovery after kidney transplantation.","volume":"79","author":"Hollmen","year":"2011","journal-title":"Kidney Int"},{"key":"R71-1-20210129","first-page":"617","article-title":". Extended preservation of the liver for clinical transplantation.","volume":"1","author":"Kalayoglu","year":"1988","journal-title":"Lancet"},{"key":"R72-1-20210129","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.transproceed.2004.11.028","article-title":". Preliminary results of a clinical randomized study comparing Celsior and HTK solutions in liver preservation for transplantation.","volume":"37","author":"Nardo","year":"2005","journal-title":"Transplant Proc"},{"key":"R73-1-20210129","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.transproceed.2006.06.071","article-title":". Randomized clinical assay for hepatic grafts preservation with University of Wisconsin or histidine-tryptophan-ketoglutarate solutions in liver transplantation.","volume":"38","author":"Meine","year":"2006","journal-title":"Transplant Proc"},{"key":"R74-1-20210129","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1097\/01.TP.0000132278.00441.CF","article-title":". A comparative prospective study of two available solutions for kidney and liver preservation.","volume":"77","author":"Pedotti","year":"2004","journal-title":"Transplantation"},{"key":"R75-1-20210129","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0140-6736(92)93212-6","article-title":". Effect of preservation solution on results of cadaveric kidney transplantation. The European Multicentre Study Group.","volume":"340","author":"Ploeg","year":"1992","journal-title":"Lancet"},{"key":"R76-1-20210129","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s001470050256","article-title":". Eurotransplant randomized multicenter kidney graft preservation study comparing HTK with UW and Euro-Collins.","volume":"12","author":"de Boer","year":"1999","journal-title":"Transpl Int"},{"key":"R77-1-20210129","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1016\/j.transproceed.2005.06.030","article-title":". Kidney transplantation from elderly donors: a prospective randomized study comparing celsior and UW solutions.","volume":"37","author":"Montalti","year":"2005","journal-title":"Transplant Proc"},{"key":"R78-1-20210129","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1097\/00007890-200110150-00016","article-title":". Kidney preservation with university of Wisconsin and Celsior solution: a prospective multicenter randomized study.","volume":"72","author":"Faenza","year":"2001","journal-title":"Transplantation"},{"key":"R79-1-20210129","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1016\/j.transproceed.2008.05.080","article-title":". Celsior versus Wisconsin solution in pancreas transplantation.","volume":"40","author":"Nicoluzzi","year":"2008","journal-title":"Transplant Proc"},{"key":"R80-1-20210129","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.transproceed.2007.01.009","article-title":". Kidney transplantation with Belzer or Custodiol solution: a randomized prospective study.","volume":"39","author":"Klaus","year":"2007","journal-title":"Transplant Proc"},{"key":"R81-1-20210129","first-page":"2405","article-title":". Randomized multicenter study for comparison of University of Wisconsin solution vs Euro-Collins solution on early renal allograft function in the non-heart-beating cadaver donor.","volume":"26","author":"Ishibashi","year":"1994","journal-title":"Transplant Proc"},{"key":"R82-1-20210129","first-page":"202","article-title":". Histidine-tryptophan-ketoglutarate versus Euro-Collins for preservation of kidneys from non-heart-beating donors.","volume":"28","author":"Moisiuk","year":"1996","journal-title":"Transplant Proc"},{"key":"R83-1-20210129","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1097\/01.TP.0000093834.05766.FD","article-title":". How to improve the quality of kidneys from non-heart-beating donors: a randomised controlled trial of thrombolysis in non-heart-beating donors.","volume":"76","author":"Gok","year":"2003","journal-title":"Transplantation"},{"key":"R84-1-20210129","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1097\/01.TP.0000120535.89925.CA","article-title":". Pancreas preservation with University of Wisconsin and Celsior solutions: a single-center, prospective, randomized pilot study.","volume":"77","author":"Boggi","year":"2004","journal-title":"Transplantation"},{"key":"R85-1-20210129","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1432-2277.2008.00773.x","article-title":". A prospective randomized multicenter trial comparing histidine-tryptophane-ketoglutarate versus University of Wisconsin perfusion solution in clinical pancreas transplantation.","volume":"22","author":"Schneeberger","year":"2009","journal-title":"Transpl Int"},{"key":"R87-1-20210129","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0022-5223(19)35018-4","article-title":". University of Wisconsin solution versus crystalloid cardioplegia for human donor heart preservation. A randomized blinded prospective clinical trial.","volume":"103","author":"Jeevanandam","year":"1992","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R88-1-20210129","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0022-5223(19)36854-0","article-title":". Cardiac preservation in patients undergoing transplantation. A clinical trial comparing University of Wisconsin solution and Stanford solution.","volume":"102","author":"Stein","year":"1991","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R89-1-20210129","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/0003-4975(93)90019-E","article-title":". University of Wisconsin versus St. Thomas Hospital solution for human donor heart preservation.","volume":"55","author":"Demertzis","year":"1993","journal-title":"Ann Thorac Surg"},{"key":"R90-1-20210129","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0022-5223(99)70047-4","article-title":". Blood versus crystalloid cardioplegia for myocardial protection of donor hearts during transplantation: a prospective, randomized clinical trial.","volume":"118","author":"Luciani","year":"1999","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R91-1-20210129","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/S0041-1345(99)00264-X","article-title":". Improved graft function using a new myocardial preservation solution: Celsior. Preliminary data from a randomized prospective study.","volume":"31","author":"Wieselthaler","year":"1999","journal-title":"Transplant Proc"},{"key":"R92-1-20210129","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/S0003-4975(01)02458-4","article-title":". A multicenter, randomized, controlled trial of Celsior for flush and hypothermic storage of cardiac allografts.","volume":"71","author":"Vega","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"R93-1-20210129","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s11748-009-0492-3","article-title":"Preservation solution for lung transplantation.","volume":"57","author":"Okada","year":"2009","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"R94-1-20210129","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1053-2498(00)00375-2","article-title":". Prospective randomized clinical study of Celsior vs University of Wisconsin in double lung transplant.","volume":"20","author":"DArmini","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"R95-1-20210129","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.healun.2010.05.031","article-title":". Low potassium dextran is superior to University of Wisconsin solution in high-risk lung transplant recipients.","volume":"29","author":"Arnaoutakis","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"R96-1-20210129","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1600-6143.2008.02478.x","article-title":". Histidine-tryptophan-ketoglutarate (HTK) is associated with reduced graft survival in deceased donor livers, especially those donated after cardiac death.","volume":"9","author":"Stewart","year":"2009","journal-title":"Am J Transplant"},{"key":"R97-1-20210129","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1600-6143.2008.02545.x","article-title":". Histidine-tryptophan-ketoglutarate (HTK) is associated with reduced graft survival of deceased donor kidney transplants.","volume":"9","author":"Stewart","year":"2009","journal-title":"Am J Transplant"},{"key":"R98-1-20210129","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1600-6143.2008.02449.x","article-title":". Histidine-tryptophan-ketoglutarate (HTK) is associated with reduced graft survival in pancreas transplantation.","volume":"9","author":"Stewart","year":"2009","journal-title":"Am J Transplant"},{"key":"R99-1-20210129","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.healun.2011.05.005","article-title":". Organ storage with University of Wisconsin solution is associated with improved outcomes after orthotopic heart transplantation.","volume":"30","author":"George","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R100-1-20210129","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1111\/j.1600-6143.2011.03614.x","article-title":". Supplementation with a new therapeutic oxygen carrier reduces chronic fibrosis and organ dysfunction in kidney static preservation.","volume":"11","author":"Thuillier","year":"2011","journal-title":"Am J Transplant"},{"key":"R101-1-20210129","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jss.2011.02.046","article-title":". Use of a third-generation perfluorocarbon for preservation of rat DCD liver grafts.","volume":"175","author":"Bezinover","year":"2012","journal-title":"J Surg Res"},{"key":"R102-1-20210129","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/bjs.7332","article-title":". Effect of polyethylene glycol-based preservation solutions on graft injury in experimental kidney transplantation.","volume":"98","author":"Thuillier","year":"2011","journal-title":"Br J Surg"},{"key":"R103-1-20210129","doi-asserted-by":"crossref","first-page":"H895","DOI":"10.1152\/ajpheart.00149.2007","article-title":". Ten-hour preservation of guinea pig isolated hearts perfused at low flow with air-saturated Lifor solution at 26degreesC: comparison to ViaSpan solution.","volume":"293","author":"Stowe","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R104-1-20210129","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/sj.ki.5000063","article-title":". Comparative efficacy of renal preservation solutions to limit functional impairment after warm ischemic injury.","volume":"69","author":"Ahmad","year":"2006","journal-title":"Kidney Int"},{"key":"R105-1-20210129","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1111\/j.1600-6143.2009.02736.x","article-title":". Combining cariporide with glyceryl trinitrate optimizes cardiac preservation during porcine heart transplantation.","volume":"9","author":"Hing","year":"2009","journal-title":"Am J Transplant"},{"key":"R106-1-20210129","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/TP.0b013e3182115b4b","article-title":". A recombinant human neuregulin-1 peptide improves preservation of the rodent heart after prolonged hypothermic storage.","volume":"91","author":"Jabbour","year":"2011","journal-title":"Transplantation"},{"key":"R107-1-20210129","first-page":"229","article-title":". A comparison of hypothermic preservation with hypothermic pulsatile perfusion in paired human kidneys.","volume":"22","author":"Sterling","year":"1971","journal-title":"Surgical forum"},{"key":"R108-1-20210129","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/00007890-198512000-00017","article-title":". Single-donor cold storage versus machine perfusion in cadaver kidney preservation.","volume":"40","author":"Alijani","year":"1985","journal-title":"Transplantation"},{"key":"R109-1-20210129","first-page":"2046","article-title":". A controlled comparison of kidney preservation by two methods: machine perfusion and cold storage.","volume":"19","author":"Heil","year":"1987","journal-title":"Transplant Proc"},{"key":"R110-1-20210129","first-page":"2047","article-title":". Preservation effect on oligo-anuria in the cyclosporine era: a prospective trial with 26 paired cadaveric renal allografts.","volume":"19","author":"Mendez","year":"1987","journal-title":"Transplant Proc"},{"key":"R111-1-20210129","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00007890-199401001-00027","article-title":". The effect of machine perfusion preservation versus cold storage on the function of kidneys from non-heart-beating donors.","volume":"57","author":"Matsuno","year":"1994","journal-title":"Transplantation"},{"key":"R112-1-20210129","doi-asserted-by":"crossref","first-page":"353","DOI":"10.5694\/j.1326-5377.1977.tb117701.x","article-title":". Preservation of cadaver of renal allografts: comparison of ice storage and machine perfusion.","volume":"2","author":"Marshall","year":"1977","journal-title":"Med J Aust"},{"key":"R113-1-20210129","first-page":"472","article-title":". Comparative study of albumin solution and cryoprecipitated plasma for renal preservation: a preliminary report.","volume":"11","author":"Feduska","year":"1979","journal-title":"Transplant Proc"},{"key":"R114-1-20210129","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/00007890-198706000-00011","article-title":"A randomized prospective trial of cold storage versus pulsatile perfusion for cadaver kidney preservation.","volume":"43","author":"Halloran","year":"1987","journal-title":"Transplantation"},{"key":"R115-1-20210129","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00007890-199008000-00011","article-title":". A prospective controlled trial of cold-storage versus machine-perfusion preservation in cadaveric renal transplantation.","volume":"50","author":"Merion","year":"1990","journal-title":"Transplantation"},{"key":"R116-1-20210129","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1399-0012.1994.tb00953.x","article-title":". Renal allograft preservation: a comparison of University of Wisconsin solution and of hypothermic continuous pulsatile perfusion.","volume":"8","author":"Veller","year":"1994","journal-title":"Clin Transplant"},{"key":"R117-1-20210129","first-page":"1474","article-title":". Comparison of cold storage and machine perfusion in the preservation of cadaver kidneys: a prospective, randomized study.","volume":"17","author":"Mozes","year":"1985","journal-title":"Transplant Proc"},{"key":"R118-1-20210129","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1034\/j.1399-0012.2003.00077.x","article-title":". Pulsatile machine perfusion vs. cold storage of kidneys for transplantation: a rapid and systematic review.","volume":"17","author":"Wight","year":"2003","journal-title":"Clin Transplant"},{"key":"R119-1-20210129","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1600-6143.2005.00910.x","article-title":". Are we frozen in time Analysis of the utilization and efficacy of pulsatile perfusion in renal transplantation.","volume":"5","author":"Schold","year":"2005","journal-title":"Am J Transplant"},{"key":"R120-1-20210129","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJMoa0802289","article-title":". Machine perfusion or cold storage in deceased-donor kidney transplantation.","volume":"360","author":"Moers","year":"2009","journal-title":"N Engl J Med"},{"key":"R121-1-20210129","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/SLA.0b013e3181ffc256","article-title":". Machine perfusion versus cold storage for the preservation of kidneys donated after cardiac death: a multicenter, randomized, controlled trial.","volume":"252","author":"Jochmans","year":"2010","journal-title":"Ann Surg"},{"key":"R122-1-20210129","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/j.1600-6143.2010.03165.x","article-title":". Cold machine perfusion versus static cold storage of kidneys donated after cardiac death: a UK multicenter randomized controlled trial.","volume":"10","author":"Watson","year":"2010","journal-title":"Am J Transplant"},{"key":"R124-1-20210129","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/jsre.1999.5652","article-title":". Prostaglandin E1 influences pulsatile preservation characteristics and early graft function in expanded criteria donor kidneys.","volume":"85","author":"Polyak","year":"1999","journal-title":"J Surg Res"},{"key":"R125-1-20210129","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00007890-200001150-00033","article-title":". Donor treatment with phentolamine mesylate improves machine preservation dynamics and early renal allograft function.","volume":"69","author":"Polyak","year":"2000","journal-title":"Transplantation"},{"key":"R126-1-20210129","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0041-1345(99)00919-7","article-title":". A useful predictor in machine perfusion preservation for kidney transplantation from non-heart-beating donors.","volume":"32","author":"Matsuno","year":"2000","journal-title":"Transplant Proc"},{"key":"R127-1-20210129","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1016\/S0041-1345(97)01036-1","article-title":". Release of alpha-glutathione S-transferase (alpha GST) and pi-glutathione S-transferase (pi GST) from ischemic damaged kidneys into the machine perfusaterelevance to viability assessment.","volume":"29","author":"Kievit","year":"1997","journal-title":"Transplant Proc"},{"key":"R128-1-20210129","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1111\/j.1600-6143.2006.01510.x","article-title":". Redox-active iron released during machine perfusion predicts viability of ischemically injured deceased donor kidneys.","volume":"6","author":"de Vries","year":"2006","journal-title":"Am J Transplant"},{"key":"R129-1-20210129","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1097\/TP.0b013e3181f5c40c","article-title":". The value of machine perfusion perfusate biomarkers for predicting kidney transplant outcome.","volume":"90","author":"Moers","year":"2010","journal-title":"Transplantation"},{"key":"R130-1-20210129","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1600-6143.2008.02165.x","article-title":"Machine perfusion for marginal liver grafts.","volume":"8","author":"Dutkowski","year":"2008","journal-title":"Am J Transplant"},{"key":"R131-1-20210129","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1600-6143.2009.02932.x","article-title":". Hypothermic machine preservation in human liver transplantation: the first clinical series.","volume":"10","author":"Guarrera","year":"2010","journal-title":"Am J Transplant"},{"key":"R132-1-20210129","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/MOT.0b013e32830fdf9a","article-title":"Machine perfusion for cardiac allograft preservation.","volume":"13","author":"Cobert","year":"2008","journal-title":"Curr Opin Organ Transplant"},{"key":"R133-1-20210129","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/TP.0b013e31823ec02a","article-title":". Use of 12-month renal function and baseline clinical factors to predict long-term graft survival: application to BENEFIT and BENEFIT-EXT trials.","volume":"93","author":"Schnitzler","year":"2012","journal-title":"Transplantation"},{"key":"R134-1-20210129","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00007890-197806000-00001","article-title":". A randomized prospective study of cadaver donor pretreatment in renal transplantation.","volume":"25","author":"Jeffery","year":"1978","journal-title":"Transplantation"},{"key":"R135-1-20210129","first-page":"1554","article-title":". Initial flush solution for donor liver procurement: lactated Ringers or UW solution A randomized, prospective trial.","volume":"23","author":"Schwartz","year":"1991","journal-title":"Transplant Proc"},{"key":"R136-1-20210129","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/00007890-199205000-00006","article-title":". A prospective randomized trial between Euro-Collins and University of Wisconsin solutions as the initial flush in hepatic allograft procurement.","volume":"53","author":"Cofer","year":"1992","journal-title":"Transplantation"},{"key":"R137-1-20210129","doi-asserted-by":"crossref","first-page":"S489","DOI":"10.1111\/j.1432-2277.1994.tb01426.x","article-title":". A prospective randomized clinical trial of liver preservation using high-sodium versus high-potassium lactobionateraffinose solution.","volume":"7","author":"Kurzawinski","year":"1994","journal-title":"Transpl Int"},{"key":"R138-1-20210129","first-page":"177","article-title":". Comparison of histidine-tryptophan-ketoglutarate (HTK) solution versus University of Wisconsin (UW) solution for organ preservation in human liver transplantation. A prospective, randomized study.","volume":"7","author":"Erhard","year":"1994","journal-title":"Transpl Int"},{"key":"R139-1-20210129","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1445-2197.1998.tb02081.x","article-title":". Cadaveric liver procurement using aortic perfusion only.","volume":"68","author":"Chui","year":"1998","journal-title":"Aust N Z J Surg"},{"key":"R140-1-20210129","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0041-1345(00)02357-5","article-title":". Randomized clinical study comparing UW and Celsior solution in liver preservation for transplantation: preliminary results.","volume":"33","author":"Nardo","year":"2001","journal-title":"Transplant Proc"},{"key":"R141-1-20210129","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1053\/jlts.2003.50161","article-title":". A multicenter pilot prospective study comparing Celsior and University of Wisconsin preserving solutions for use in liver transplantation.","volume":"9","author":"Cavallari","year":"2003","journal-title":"Liver Transpl"},{"key":"R142-1-20210129","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1016\/j.transproceed.2006.08.032","article-title":". Preservation of the liver graft with Celsior solution.","volume":"38","author":"Garcia-Gil","year":"2006","journal-title":"Transplant Proc"},{"key":"R143-1-20210129","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-6143.2006.01595.x","article-title":". Clinical trial of the pan-caspase inhibitor, IDN-6556, in human liver preservation injury.","volume":"7","author":"Baskin-Bey","year":"2007","journal-title":"Am J Transplant"},{"key":"R144-1-20210129","first-page":"7","article-title":". A randomized study comparing IGL-1 to the University of Wisconsin preservation solution in liver transplantation.","volume":"15","author":"Dondero","year":"2010","journal-title":"Ann Transplant"},{"key":"R145-1-20210129","first-page":"2370","article-title":". Efficacy of UW vs Euro-Collins solution in paired cadaveric kidneys: a prospective study.","volume":"23","author":"Hefty","year":"1991","journal-title":"Transplant Proc"},{"key":"R146-1-20210129","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00007890-199301000-00007","article-title":". Prospective randomized comparison of University of Wisconsin and UW-modified, lacking hydroxyethyl-starch, cold-storage solutions in kidney transplantation.","volume":"55","author":"Baatard","year":"1993","journal-title":"Transplantation"},{"key":"R147-1-20210129","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0002-9610(81)90137-9","article-title":". Prospective controlled trial of cryoprecipitated plasma, plasma protein fraction and serum albumin solution for kidney preservation.","volume":"141","author":"Cho","year":"1981","journal-title":"Am J Surg"},{"key":"R148-1-20210129","first-page":"202","article-title":". Glutathione supplementation during cold ischemia does not confer early functional advantage in renal transplantation.","volume":"70","author":"Polyak","year":"2000","journal-title":"Transplantation"},{"key":"R149-1-20210129","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0041-1345(00)02343-5","article-title":". Preservation of non-heart-beating donor kidneys: a clinical prospective randomised case-control study of machine perfusion versus cold storage.","volume":"33","author":"van der Vliet","year":"2001","journal-title":"Transplant Proc"},{"key":"R150-1-20210129","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.transproceed.2004.04.083","article-title":". Pushing the envelope in renal preservation; improved results with novel perfusate modifications for pulsatile machine perfusion of cadaver kidneys.","volume":"36","author":"Guarrera","year":"2004","journal-title":"Transplant Proc"},{"key":"R151-1-20210129","first-page":"14","article-title":". The early and long term function and survival of kidney allografts stored before transplantation by hypothermic pulsatile perfusion. A prospective randomized study.","volume":"14","author":"Kwiatkowski","year":"2009","journal-title":"Ann Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00007890-201209150-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T21:29:56Z","timestamp":1743974996000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201209150-00001"}},"subtitle":["Opportunities and Issues"],"short-title":[],"issued":{"date-parts":[[2012,9,15]]},"references-count":148,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3182547537","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9,15]]}}}